Takeaways: Lenivia’s launch in Canada and the EU adds a three‑month, injectable biologic into Zoetis’ canine OA toolkit, which is likely to shift more chronic pain management away from dail...
Takeaways: AstraZeneca deepens its Saphnelo franchise in Canada by adding a self‑administered SC autoinjector on top of IV, improving convenience and persistency in a chronic, mostly f...
